Cortical hyperexcitability and mechanism of medication-overuse headache

Cephalalgia

Volumn 30, Issue 9, 2010, Pages 1101-1109

  Supornsilpchai, Weera ^a   Maneesri Le Grand, Supang ^a   Srikiatkhachorn, Anan ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

cortical excitability; cortical spreading depression; medication overuse headache; paracetamol; trigeminal nociception

Indexed keywords

PARACETAMOL; PROTEIN FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN DEVELOPMENT; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORTICAL HYPEREMIA; DRUG INDUCED HEADACHE; ELECTROCORTICOGRAPHY; HEADACHE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; MALE; NERVE EXCITABILITY; NOCICEPTION; NONHUMAN; PARIETAL LOBE; PROTEIN EXPRESSION; RAT; SINGLE DRUG DOSE; SPREADING CORTICAL DEPRESSION; TRIGEMINAL NERVE;

ACETAMINOPHEN; ACUTE DISEASE; ANALGESICS, NON-NARCOTIC; ANIMALS; CHRONIC DISEASE; CORTICAL SPREADING DEPRESSION; HEADACHE DISORDERS, SECONDARY; HYPEREMIA; MALE; NOCICEPTORS; PARIETAL LOBE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; TRIGEMINAL NUCLEI;

EID: 78449298274     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102409355600     Document Type: Article

References (27)

1. Ayata C., Jin H., Kudo C., Dalkara T., Moskowitz MA Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol 2006 ; 59: 652-661.
2. Supornsilpchai W., Sanguanrangsirikul S., Maneesri S., Srikiatkhachorn A. Serotonin depletion, cortical spreading depression and trigeminal nociception. Headache 2006 ; 46: 34-39.
3. Sarchielli P., Alberti A., Russo S., et al. Nitric oxide pathway, Ca2+, and serotonin content in platelets from patients suffering from chronic daily headache. Cephalalgia 1999 ; 19: 810-816.
4. Brennan KC, Romero Reyes MR, Lpez Valds HE, Arnold AP, Charles AC Reduced threshold for cortical spreading depression in female mice. Ann Neurol 2007 ; 61: 603-606.
5. Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB Transformed migraine and medication overuse in a tertiary headache centre-clinical characteristics and treatment outcomes. Cephalalgia 2004 ; 24: 483-490.
6. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates, 4 th edn. New York: Academic Press, 1998.
7. Kitahara Y., Taga K., Abe H., Shimoji K. The effects of anesthetics on cortical spreading depression elicitation and c-fos expression in rats. J Neurosurg Anesthesiol 2001 ; 13: 26-32.
8. Kudo C., Nozari A., Moskowitz MA, Ayata C. The impact of anesthetics and hyperoxia on cortical spreading depression. Exp Neurol 2008 ; 212: 201-206.
9. Wernsmann B., Pape HC, Speckmann EJ, Gorji A. Effect of cortical spreading depression on synaptic transmission of rat hippocampal tissues. Eur J Neurosci 2006 ; 23: 1103-1110.
10. Berger M., Speckmann EJ, Pape HC, Gorji A. Spreading depression enhances human neocortical excitability in vitro. Cephalalgia 2008 ; 28: 558-562.
11. van den Maagdenberg Amjm, Pietrobon DP, Pizzorusso T., et al. A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 2004 ; 41: 701-710.
12. Tong CK, Chesler M. Modulation of spreading depression by changes in extracellular pH. J Neurophysiol 2000 ; 84: 2449-2457.
13. Sachs M., Pape HC, Speckmann EJ, Gorji A. The effect of estrogen and progesterone on spreading depression in rat neocortical tissues. Neurobiol Dis 2007 ; 25: 27-34.
14. Vanmolkot KR, Kors EE, Hottenga JJ, et al. Novel mutations in the Na+,K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann Neurol 2003 ; 54: 360-366.
15. Mancini F., Landolfi C., Muzio M., et al. Acetaminophen down-regulates interleukin-1beta-induced nuclear factor-kappaB nuclear translocation in a human astrocytic cell line. Neurosci Lett 2003 ; 353: 79-82.
16. Busija DW, Bari F., Domoki F., Horiguchi T., Shimizu K. Mechanisms involved in the cerebrovascular dilator effects of cortical spreading depression. Prog Neurobiol 2008 ; 86: 379-395.
17. Kis B., Snipes JA, Simandle SA, Busija DW Acetaminophen-sensitive prostaglandin production in rat cerebral endothelial cells. Am J Physiol 2005 ; 288: R897-R902.
18. Tripathy D., Grammas P. Acetaminophen protects brain endothelial cells against oxidative stress. Microvasc Res 2009 ; 77: 289-296.
19. Mallet C., Daulhac L., Bonnefont J., et al. Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia. Pain 2008 ; 139: 190-200.
20. Bonnefont J., Daulhac L., Etienne M., et al. Acetaminophen recruits spinal p42/p44 MAPKs and GH/IGF-1 receptors to produce analgesia via the serotonergic system. Mol Pharmacol 2007 ; 71: 407-415.
21. Girard P., Pansart Y., Copp MC, Niedergang B., Gillardin JM Modulation of paracetamol and nefopam antinociception by serotonin 5-HT(3) receptor antagonists in mice. Pharmacology 2009 ; 83: 243-246.
22. Pickering G., Loriot MA, Libert F., Eschalier A., Beaune P., Dubray C. Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism. Clin Pharmacol Ther 2006 ; 79: 371-378.
23. Pickering G., Estve V., Loriot MA, Eschalier A., Dubray C. Acetaminophen reinforces descending inhibitory pain pathways. Clin Pharmacol Ther 2008 ; 84: 47-51.
24. Srikiatkhachorn A., Tarasub N., Govitrapong P. Effect of chronic analgesic exposure on the central serotonin system. A possible mechanism of analgesic abuse headache. Headache 2000 ; 40: 343-350.
25. Cohen Z., Bouchelet I., Olivier A., et al. Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: molecular and pharmacologic characterization. J Cereb Blood Flow Metab 1999 ; 19: 908-917.
26. Gold L., Back T., Arnold G., et al. Cortical spreading depression-associated hyperemia in rats: involvement of serotonin. Brain Res 1998 ; 783: 188-193.
27. Reuter U., Salomone S., Ickenstein GW, Waeber C. Effects of chronic sumatriptan and zolmitriptan treatment on 5-HT receptor expression and function in rats. Cephalalgia 2004 ; 24: 398-407.